These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 339937)

  • 41. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 42. [Experience in the ambulatory treatment of primary arterial hypertension with a fixed oxprenolol-chlorthalidone combination].
    Zampaglione G; Ferrari O; Bianchi C; Bonifazi C; Coppetti S; Costanza G; Lanzarini L; Ricevuti A; Rinaldo R; Rizzi GM; Tavecchi L; Ziletti G; Distante S
    G Clin Med; 1980 Oct; 61(10):776-88. PubMed ID: 7239053
    [No Abstract]   [Full Text] [Related]  

  • 43. [Continuous 24-hour registration of intra-arterial pressure in basal states and during therapy with a fixed slow-release oxprenolol-chlorthalidone combination, administered once a day].
    Fariello R; Alicandri C; Boni E; Montini E; Zaninelli A; Agabiti-Rosei E; Motolese M; Muiesan G
    G Ital Cardiol; 1984 Feb; 14(2):121-6. PubMed ID: 6714549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of hypertension with a new combination of beta blocking agents and saluretics].
    Deibert K
    Med Welt; 1980 Sep; 31(36):1288-90. PubMed ID: 7442528
    [No Abstract]   [Full Text] [Related]  

  • 45. Once daily slow-release hydralazine in hypertension.
    O'Boyle CP; Kelly J; O'Brien ET; O'Malley K
    Ir Med J; 1981 Apr; 74(4):115-6. PubMed ID: 7228629
    [No Abstract]   [Full Text] [Related]  

  • 46. [Comparative trial of combined oxprenolol-chlorthalidone and a beta-blockader and diuretic separately in primary arterial hypertension].
    Luna RL; Faerchtein I; de Vasconcelos EM; Arslanian L; de La Nuez SB; Pereira WQ; Puppin S; Campos JC; Roque AF; Kastansky I
    Arq Bras Cardiol; 1979 Oct; 33(4):311-20. PubMed ID: 398212
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy of a combination of diuretic, beta-blocker and vasodilator in the treatment of hypertension in general practice.
    Forrest WA
    Br J Clin Pract; 1978 Nov; 32(11):326-32. PubMed ID: 737111
    [No Abstract]   [Full Text] [Related]  

  • 48. Experience with Trasidrex in the management of inadequately controlled hypertension in general practice.
    Forrest WA
    Br J Clin Pract; 1980 May; 34(5):140-3. PubMed ID: 6893270
    [No Abstract]   [Full Text] [Related]  

  • 49. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN
    Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of refractory hypertension with a fixed oxprenolol/chlorthalidone/hydralazine combination. Results of an open multicenter trial].
    Krönig B; Wendt G
    Med Welt; 1983 Sep; 34(35):941-4. PubMed ID: 6355745
    [No Abstract]   [Full Text] [Related]  

  • 51. The anti-hypertensive efficacy of combined alpha- and beta-adrenoreceptor blockade with phentolamine-oxprenolol or with labetalol (AH 5158).
    Johnson BF; LaBrooy J; Munro-Faure AD
    Clin Sci Mol Med Suppl; 1976 Dec; 3():505s-507s. PubMed ID: 799558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A multicentre study examining the substitution of Trasidrex for the free combination of Slow-Trasicor and Navidrex-K.
    Ebbutt AF; Elsdon-Dew RW
    J Int Med Res; 1979; 7(6):524-7. PubMed ID: 520655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies with sustained-release verapamil in essential hypertension.
    Silke B
    Br J Clin Pract Suppl; 1988 Apr; 60():53-7. PubMed ID: 3151272
    [No Abstract]   [Full Text] [Related]  

  • 54. Once daily beta-blocker in hypertension--oxprenolol slow-release.
    Gordon RD; Ziesak M; Rowe WS; Strakosch CR; Row G
    J Int Med Res; 1981; 9(1):6-11. PubMed ID: 7009256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bethanidine and oxprenolol in hypertension--a study in combination therapy.
    Rowlands G; McConachie NA; Currie WJ
    Practitioner; 1977 Jul; 219(1309):105-8. PubMed ID: 329261
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment of essential hypertension with Transicor 80 and Esidrex K under medical practice conditions].
    Mauracher EH; Rivier JL
    Schweiz Med Wochenschr; 1976 Mar; 106(10):350-4. PubMed ID: 1251151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
    Schröder R
    Z Kardiol; 1985; 74 Suppl 6():165-72. PubMed ID: 2869616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of two oxprenolol oral osmotic (OROS) delivery systems in patients with essential hypertension.
    McInnes GT; Brodie MJ
    Eur J Clin Pharmacol; 1988; 34(6):605-11. PubMed ID: 3169112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Ergometric studies for supplementary evaluation of antihypertensive therapy].
    Franz IW; Lohmann FW
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():325-7. PubMed ID: 347807
    [No Abstract]   [Full Text] [Related]  

  • 60. Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects.
    Costa FV; Borghi C; Ambrosioni E
    Clin Ther; 1984; 6(5):708-18. PubMed ID: 6383615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.